Literature DB >> 24682953

GSTM1 polymorphism and lung cancer risk among East Asian populations: a meta-analysis.

Yan Zhao1, Junjie Zeng, Yanxi Zhang, Su Lu, Erjiang Zhao, Ziming Huang, Weiquan Lu.   

Abstract

GSTM1 gene encodes a key enzyme involved in the metabolism of xenobiotics, and its polymorphisms have been related to individual susceptibility to several malignancies. Many molecular epidemiological studies were performed to investigate the association between the GSTM1 null polymorphism and lung cancer susceptibility in East Asia. However, the results were inconsistent. In order to derive a more precise estimation, we conducted this meta-analysis involving 5,909 lung cancer cases and 7,067 controls from 35 studies. We used crude odds ratios (ORs) with 95 % confidence intervals (CIs) to assess the association between GSTM1 null genotype and the risk of lung cancer. Our study found that the GSTM1 null genotype appeared to be a significant risk factor for lung cancer in East Asia population (OR = 1.30, 95 % CI = 1.17-1.45, P heterogeneity < 0.0001, and I (2) = 54.0 %).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24682953     DOI: 10.1007/s13277-014-1832-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  81 in total

1.  GSTM1, smoking and lung cancer: a case-control study.

Authors:  I Stücker; I de Waziers; S Cenée; J Bignon; A Depierre; B Milleron; P Beaune; D Hémon
Journal:  Int J Epidemiol       Date:  1999-10       Impact factor: 7.196

2.  [CYP1A1 polymorphisms, lack of glutathione S-transferase M1 (GSTM1), cooking oil fumes and lung cancer risk in non-smoking women].

Authors:  Xiao-Xia Zhu; Cheng-Ping Hu; Qi-Hua Gu
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2010-11

Review 3.  Mammalian class theta GST and differential susceptibility to carcinogens: a review.

Authors:  S Landi
Journal:  Mutat Res       Date:  2000-10       Impact factor: 2.433

4.  Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons.

Authors:  R P Deutsch-Wenzel; H Brune; G Grimmer; G Dettbarn; J Misfeld
Journal:  J Natl Cancer Inst       Date:  1983-09       Impact factor: 13.506

5.  Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study.

Authors:  J Seidegård; R W Pero; M M Markowitz; G Roush; D G Miller; E J Beattie
Journal:  Carcinogenesis       Date:  1990-01       Impact factor: 4.944

Review 6.  Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis.

Authors:  C Carlsten; G S Sagoo; A J Frodsham; W Burke; J P T Higgins
Journal:  Am J Epidemiol       Date:  2008-02-12       Impact factor: 4.897

Review 7.  Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review.

Authors:  H Raunio; K Husgafvel-Pursiainen; S Anttila; E Hietanen; A Hirvonen; O Pelkonen
Journal:  Gene       Date:  1995-06-14       Impact factor: 3.688

8.  Combined effect of polymorphic GST genes on individual susceptibility to lung cancer.

Authors:  S T Saarikoski; A Voho; M Reinikainen; S Anttila; A Karjalainen; C Malaveille; H Vainio; K Husgafvel-Pursiainen; A Hirvonen
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

9.  Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies.

Authors:  Zheng Ye; Honglin Song; Julian P T Higgins; Paul Pharoah; John Danesh
Journal:  PLoS Med       Date:  2006-03-07       Impact factor: 11.069

10.  The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer.

Authors:  B Ketterer; J M Harris; G Talaska; D J Meyer; S E Pemble; J B Taylor; N P Lang; F F Kadlubar
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

View more
  4 in total

1.  Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis.

Authors:  Wen Li; Li-Qiang Song; Jian Tan
Journal:  Tumour Biol       Date:  2014-06-18

2.  Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on lung cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.

Authors:  Wen-Ping Zhang; Chen Yang; Ling-Jun Xu; Wei Wang; Liang Song; Xiao-Feng He
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

3.  Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) Polymorphisms and Lung Cancer Risk among a Select Group of Iranian People

Authors:  Glavizh Adibhesami; Gholam Reza Shahsavari; Ali Amiri; Amir Nader Emami Razavi; Masoud Shamaei; Mehdi Birjandi
Journal:  Asian Pac J Cancer Prev       Date:  2018-10-26

4.  Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.

Authors:  Babatunde Adedokun; Zhaohui Du; Guimin Gao; Thomas U Ahearn; Kathryn L Lunetta; Gary Zirpoli; Jonine Figueroa; Esther M John; Leslie Bernstein; Wei Zheng; Jennifer J Hu; Regina G Ziegler; Sarah Nyante; Elisa V Bandera; Sue A Ingles; Michael F Press; Sandra L Deming-Halverson; Jorge L Rodriguez-Gil; Song Yao; Temidayo O Ogundiran; Oladosu Ojengbede; William Blot; Melissa A Troester; Katherine L Nathanson; Anselm Hennis; Barbara Nemesure; Stefan Ambs; Peter N Fiorica; Lara E Sucheston-Campbell; Jeannette T Bensen; Lawrence H Kushi; Gabriela Torres-Mejia; Donglei Hu; Laura Fejerman; Manjeet K Bolla; Joe Dennis; Alison M Dunning; Douglas F Easton; Kyriaki Michailidou; Paul D P Pharoah; Qin Wang; Dale P Sandler; Jack A Taylor; Katie M O'Brien; Cari M Kitahara; Adeyinka G Falusi; Chinedum Babalola; Joel Yarney; Baffour Awuah; Beatrice Addai-Wiafe; Stephen J Chanock; Andrew F Olshan; Christine B Ambrosone; David V Conti; Elad Ziv; Olufunmilayo I Olopade; Montserrat Garcia-Closas; Julie R Palmer; Christopher A Haiman; Dezheng Huo
Journal:  Nat Commun       Date:  2021-07-07       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.